GB-Salisbury: Pharma in vitro metabolism

NOTE: This notice was updated on 06 August 2016 for the following reason: Adjustment to description (Section 4) to adjust typing errorsIn vitro metabolism of the API being developed by Dstl and how this will be used to improve the understanding of the drugs as the project moves forwards to be completed to Good Laboratory to clinical trials. API must be completed to Good Laboratory Practice (GLP). Only Suppliers that have the mandatory GLP systems in place should express interest in this requirement.